Hong Xin
Senior Director, Oncology Scientific Innovation Johnson & Johnson
Hong Xin, Ph.D., is Senior Director, External Innovation Search & Evaluation, Eastern US at Johnson & Johnson Innovation – Boston Innovation Center, where she develops early-stage innovation pipelines aligned with the Janssen oncology franchise. She previously implemented strategy for the Asia-Pacific Innovation Center in Korea and spent over a decade in drug discovery within Janssen R&D, gaining deep expertise across therapeutic areas and emerging platform technologies. Her work focuses on sourcing and advancing transformative science toward novel therapeutic development.
Seminars
Take your seat across the table from pharma and VC leaders actively evaluating emerging platforms in this interactive roundtable setting. Understand their therapeutic interests and investment considerations, then showcase your pipeline and align on partnership expectations through rare face-to-face interactions to ignite interest in your pipeline and cultivate collaborative, strategic partnerships.
- Understand pharma and VC therapies of interest, considering in vivo and beyond to identify high-value opportunities
- For pharma and investors, engage with senior leaders from pioneering biotech and academics early to uncover opportunities for collaboration. • For biotech, gain actionable insights by hearing what your peers are developing and understanding first-hand the direction of pharma and biotech innovation
- Leave with new connections, strategic alignment opportunities, and practical knowledge to advance your projects
- Identifying the ideal development stage for engagement to ensure timely and effective collaboration
- Detailing therapies of interest, considering in vivo and beyond to identify high-value opportunities
- Discussing collaboration processes beyond initial interest to secure
- Connect directly with leading experts in an interactive roundtable setting, sharing your work and showcasing your assets in focused, face-to-face conversations
- For pharma and investors, engage with senior leaders from pioneering biotech and academics early to uncover opportunities for collaboration
- For biotech, gain actionable insights by hearing what your peers are developing and understand first-hand the direction of pharma and biotech innovation
- Leave with new connections, strategic alignment opportunities, and practical knowledge to advance your projects
